Skip to Main Content

As the United Nations gears up for a high-level meeting on combating a global tuberculosis epidemic, Doctors Without Borders is urging Johnson & Johnson (JNJ) to widen access for a medicine that the advocacy group maintained is too costly for many countries.

In a Sept. 17 letter to the company, Doctors Without Borders argued that an “affordable and sustainable” supply of Sirturo is increasingly needed, especially after the World Health Organization recently recommended the drug as the backbone for treating multi-drug resistant tuberculosis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.